Royce & Associates LP Omnicell, Inc Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Omnicell, Inc stock. As of the latest transaction made, Royce & Associates LP holds 18,597 shares of OMCL stock, worth $789,814. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,597Holding current value
$789,814% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding OMCL
# of Institutions
277Shares Held
44.6MCall Options Held
224KPut Options Held
35.7K-
Black Rock Inc. New York, NY8.18MShares$348 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.53MShares$235 Million0.0% of portfolio
-
State Street Corp Boston, MA2.27MShares$96.3 Million0.0% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$65.7 Million0.43% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.25MShares$53 Million0.01% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $1.88B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...